THERE IS STILL A CONTINUED PUSH TO GET MORE AND MORE PEOPLE VACCINATED BUT SOME PEOPLE
CANNOT GET VACCINATED
ESPECIALLY KIDS UNDER A CERTAIN
AGE THAT RAISES MORE QUESTIONS.
>> WHEN IT COMES TO COVID-19
AND WHERE WE ARE IN THIS
PANDEMIC SO IN TODAY’S KSAT QNA
WE’D LIKE TO BRING IN DOCTOR
TEST BARTON A PEDIATRIC
INFECTIOUS DISEASE SPECIALIST
WITH UT HEALTH SAN ANTONIO,
DOCTOR MARTIN FIRST OF ALL
THANK YOU FOR YOUR TIME, THANKS
FOR
BEING HERE. LET’S TALK ABOUT
ONE BIG CONCERN THAT’S BEEN
MAKING HEADLINES LATELY FOR
KIDS WHO
HAVE RECEIVED THE VACCINE.
THE ISSUE OF MAYO CARD ITIS
WHAT DO WE NEED TO KNOW ABOUT
THIS.
>> SO IT IS IS INFLAMMATION OF
>> HEART MUSCLE.
>> AND.
>> IT’S SOMETHING THAT WE WE
SEE IT’S NOT COMMON. IT’S A
FAIRLY RARE. I THINK THAT WE DO
SEE IT EVERYWHERE. MANY CASES
AND THEY’RE OFTEN THE CHILDREN
RELATED TO OTHER VIRUSES.
>> SO THERE ARE LOTS
OF IT OTHER RESPIRATORY
VIRUSES, INCLUDING TOM COLE R
US IS THAT THAT USUALLY ARE THE
CAUSE OF MY THAT IS AND DURING
THE COVID PANDEMIC
OF COURSE WE’VE SEEN WE’VE SEEN
MY THAT IS AS ONE OF THE MANY.
PARTY AT WHICH PATIENTS THAT PEOPLE WHO GET COVID CAN HAPPEN. INCLUDING IN CHILDREN.
SO
OF COURSE WITH THE ROLLOUT OF
THE VACCINE. THERE.
I HAVE BEEN REPORTED SOME CASES
IN MY RIGHT IS TEENAGERS AND
YOUNG ADULTS YOUNG ADULTS UNDER
THE AGE OF 39 WE REPORTED
TO HEART. CASES OF MARKET THAT HAS SOME TIPS FROM WHAT I CAN TELL THERE’S BEEN SOME PART
ABOUT 300 CASES REPORTED THAT
ARE BEING INVESTIGATED.
AND THOSE COMPLICATIONS DOCTOR
OR THOSE KIND OF LEADING TO
SOME VACCINE. HESITANCY WE’VE
SEEN IT IN THE ADULTS THERE WAS
THE GROUP THAT WANTED TO GET
THE VACCINE VERY EARLY ON WHEN
IT CAME OUT.
>> IT’S BEEN OUT A COUPLE WEEKS
NOW FOR THE KIDS 12 AND UP I
KNOW I WAITED BEFORE I TOOK MY
12 YEAR-OLD DAUGHTER TO GET IT
I WANTED TO KIND OF SEE WHAT
WAS HAPPENING IF THERE ARE ANY
ADVERSE REACTIONS. BUT ARE WE SEEING THE SAME LEVEL OF HESITANCY FOR PARENTS AND THE
TEENS AS WE SEE FOR SOME OF THE
ADULTS WHEN IT COMES TO GETTING
THE SHOTS.
>> WE ARE WE SEEING
DEFINITELY A DECLINE IN THE IN
THE DEMAND FOR VACCINE
IN THE.
>> 12 TO 17 YEAR AGE RANGE
IN AND IT DOES SEEM TO
COINCIDE WITH AND NEWS ABOUT
THE MY NAME IS
IT’S REALLY TOO BAD BECAUSE
BECAUSE HONESTLY YOUR RISK
OF HAVING MY POINT IS WE’RE
QUIET COMPLICATIONS
OF COVID IT’S MUCH HIGHER THAN
THE RISK OF HAVING MY KIDS WITH
BACK SCENE AND THE CASES THAT
THEY’VE INVESTIGATED SO FAR.
THEY’VE BEEN GENERALLY MILD WE
AND THEY’VE RECOVERED. SO.
SO THERE’S STILL
YOU KNOW IT’S TOO BAD BECAUSE
REALLY THAT THE BENEFIT OF THE
VACCINE OUT WAYS THAT STRESS.
IT IS A RISK AND IT’S SOMETHING
THAT WE ABSOLUTELY NEED TO BE
MONITORING AND AND IT CAN LEAD
TO BE AWARE.
TO YOU KNOW WATCH OR
JUST THE SHORTNESS OF BREATH
AND HAVE A LONG WAY TO DO IT
YOU HAVE TO GET VACCINATED
THAT IT’S UNFORTUNATE BUT I
THINK IT’S MAKING PEOPLE
HESITANT TO TO GET THE VACCINE.
>> ANOTHER ISSUE THAT WE’RE
DEALING WITH RIGHT NOW THE
DELTA VARIANT THAT IS SOMETHING
THAT IS ON A LOT OF PEOPLE’S
MINDS WHEN IT COMES TO THE
VACCINE. HOW IS THIS.
HOW IS THE VACCINE HOLDING UP
TO THIS VARIANT. SO HOW DOES IT
SEEM TO BE WORKING IN CHILDREN.
>> SO WE DON’T TYPICALLY HAVE INFORMATION ABOUT. CHILDREN AND THE VACCINE AND THE DELTA
VARIANT.
>> BUT WE WE
ARE GETTING NEW LIFE MORE AND
MORE INFORMATION ABOUT HOW
EFFECTIVE THE VACCINES APPEAR
TO BE.
>> AGAINST THE DELTA VARIANT.
AND IT LOOKS LIKE THE MRNA
VACCINE THAT PFIZER AND MODERNA
VACCINES. I STILL ARE QUITE
INFECTED.
THEY’RE NOT AS AFFECTED AS THEY
ARGUE IT’S THE SORT OF STANDARD
A STRAIN THAT WE BEGIN WITH.
THAT’S IT FOR INSTANCE RATHER
THAN WE DID 95% EFFECTIVENESS
AGAINST SEVERE INFECTION WITH A
NAME LIKE AN 80% EFFECTIVENESS
AGAINST SEVERE ACTION, THE BEST
STILL PRETTY GOOD.
AND SO THERE
THAT’S REALLY PROMISING IT ALSO
I THINK THERE’S INFORMATION
THAT THE ASTRAZENECA VACCINE.
THAT SCENE GET
IN EUROPE. THE HOUSE IS
MAINTAINING SOME AFFECTED
MISSING RELAY HEAR ABOUT IT.
>> AND THEN REAL QUICK, WHAT IS
THE TIMELINE LOOK LIKE RIGHT
NOW FOR EXPANDING THE SHOTS TO
12 AND UNDER I KNOW THERE’S
TRIALS GOING ON WHERE THOSE
STAND AND HOW DOES THAT LOOK AS
WE GO INTO THE FOG CLOSER TO
SCHOOL STARTING UP AGAIN.
>> YEAH SO I THINK PRETTY
MUCH ALL THE COMPANIES ARE
DOING ARE DOING VACCINE TRIALS
IN YOUNGER CHILDREN EVEN DOWN
TO INTENSIVE SICK.
AND SO WE SHOULD BE GETTING
THE CLUB TRIAL DATE OF THOSE
COWS AGAIN, MOSTLY AROUND.
>> APRIL MARCHING BECAUSE THE
VERY FIRST TRIALS.
START SO WE SHOULD BE GETTING
THAT INFORMATION.
HOPEFULLY IF THERE IS THAT IT MEANS RESPONSES LIVE ENRICH THEIRS. CHANGES THAT THEY THAT
THEY NEED THEY WILL.
WE SHOULD HOPEFULLY HAVE AND.
YOU KNOW EMERGENCY USE
AUTHORIZATION TYPE OF APPROVAL.
PERHAPS PART OF THE FALL.
FINGERS CROSSED THAT IT’S TIME
FOR SCHOOLS, STARTING.
>> ALL RIGHT WE’LL WAIT AND SEE WHAT HAPPENS DOCTOR TEST BARTON PEDIATRIC INFECTIOUS DISEASE